Affiliation:
1. Institute of Virology, University Medical Center Freiburg, Medical Faculty, University of Freiburg, 79104 Freiburg, Germany
Abstract
Recombinant adenoviruses are widely used in clinical and laboratory applications. Despite the wide variety of available sero- and genotypes, only a fraction is utilized in vivo. As adenoviruses are a large group of viruses, displaying many different tropisms, immune epitopes, and replication characteristics, the merits of translating these natural benefits into vector applications are apparent. This translation, however, proves difficult, since while research has investigated the application of these viruses, there are no universally applicable rules in vector design for non-classical adenovirus types. In this paper, we describe a generalized workflow that allows vectorization, rescue, and cloning of all adenoviral species to enable the rapid development of new vector variants. We show this using human and simian adenoviruses, further modifying a selection of them to investigate their gene transfer potential and build potential vector candidates for future applications.
Funder
German Ministry of Education and Research
Deutsche Forschungsgemeinschaft
Reference58 articles.
1. Adenoviruses in Immunocompromised Hosts;Clin. Microbiol. Rev.,2008
2. Adenovirus Receptors;Zhang;J. Virol.,2005
3. Immune Evasion by Adenovirus E3 Proteins: Exploitation of Intracellular Trafficking Pathways;Windheim;Curr. Top. Microbiol. Immunol.,2004
4. Viral Vector-based Gene Therapies in the Clinic;Zhao;Bioeng. Transl. Med.,2022
5. Gene Therapy Leaves a Vicious Cycle;Goswami;Front. Oncol.,2019